(Q50802107)

English

Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective.

scientific article published on 3 April 2007

Statements

Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit